Pharmaceutical giant Pfizer Inc. is getting involved in the medical cannabis industry through the $6.7 billion, all-cash acquisition of Arena Pharmaceuticals, a California-based company specializing in autoimmune and cardiovascular treatments, who also has a cannabinoid medication currently in their pipeline.   The two publicly traded companies confirmed the deal last week. As per the agreement, Pfizer … Continue reading Pfizer Entering Cannabis Space Through $6.7 Billion All-Cash Acquisition